ROCHESTER, MI--(Marketwired - Jan 3, 2014) - OPTIMIZERx Corp. (
The Company's Chief Executive Officer and Chairman Mr. David Harrell added, "We are very pleased to have negotiated this extension at more favorable terms and am confident we will swiftly complete this transaction per the high interest expressed from both strategic and financial investors in our proven innovation, growth and performance -- as well as OPTIMIZERx's unique position to serve leading pharmaceutical and healthcare companies. Additionally, this provides an ideal opportunity to improve and clean up our capital structure."
About OPTIMIZERx Corp.: OPTIMIZERx Corp. (
For further Investor Information on OPTIMIZERx Corp., please contact: Christopher Schreiber, Taglich Brothers, at 917-445-6207
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.